Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma
about
Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.Genotyping of cutaneous melanoma.Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.Which melanoma patient carries a BRAF-mutation? A comparison of predictive models.The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy.Variables that influence BRAF mutation probability: A next-generation sequencing, non-interventional investigation of BRAFV600 mutation status in melanoma.EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P2860
Q30252150-8AF5658E-DAE2-450D-B0C2-550102355CE5Q33605879-79AF3932-E596-45EA-875A-E2B2BD95A99BQ34667738-DEEF641B-B5C4-4D4D-9E57-B5192E14BB27Q35794989-C27184DC-3E10-4304-8322-81C433025693Q35801085-953F568C-217F-47AB-AAF5-2452D99335C4Q37174935-4E4127E6-0489-47B2-98B9-E6E37E0A3DF3Q37392661-8F356360-126B-4FC7-BDF1-97F2AB36D1ECQ41696842-B5E9AD03-14E5-4CA2-81FD-6E0320DBE41DQ47103823-0C62FFCE-1ADC-480B-8993-FFEDC928015BQ50202965-CAEAC65A-C304-4D03-8D43-74D1FC4EF0BFQ57569466-F0254F09-77A7-447B-BD6E-B78CC66A28E8
P2860
Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Survival according to BRAF-V60 ...... patients with primary melanoma
@en
Survival according to BRAF-V60 ...... atients with primary melanoma.
@nl
type
label
Survival according to BRAF-V60 ...... patients with primary melanoma
@en
Survival according to BRAF-V60 ...... atients with primary melanoma.
@nl
prefLabel
Survival according to BRAF-V60 ...... patients with primary melanoma
@en
Survival according to BRAF-V60 ...... atients with primary melanoma.
@nl
P2093
P2860
P50
P1433
P1476
Survival according to BRAF-V60 ...... patients with primary melanoma
@en
P2093
Annette Pflugfelder
Benjamin Weide
Christian Busch
Claus Garbe
Diana Meckbach
Friedegund Meier
Markus Hantschke
Petra Büttner
Sven Perner
P2860
P304
P356
10.1371/JOURNAL.PONE.0086194
P407
P50
P577
2014-01-24T00:00:00Z